University of Leicester researchers have developed ONCO-ACS, an AI-powered model to predict mortality, bleeding, and ischaemic events in cancer patients after heart attacks.
Key Details
- 1ONCO-ACS is an AI model combining cancer-related and standard clinical data to predict death, bleeding, or cardiovascular events within six months post-heart attack.
- 2The study analyzed data from over 1 million heart attack patients, including more than 47,000 with cancer, from England, Sweden, and Switzerland.
- 3Results showed nearly one in three cancer patients died within six months, one in 14 suffered major bleeding, and one in six had another cardiovascular event.
- 4The model is published in The Lancet and funded by Cancer Research UK and the British Heart Foundation.
- 5The tool aims to guide personalized treatment decisions and design future trials for this complex patient group.
Why It Matters
This model addresses a significant clinical gap by offering tailored risk assessment for cancer patients post-heart attack, a group with limited guidance so far. Its real-world data approach and integration potential could improve patient outcomes and inform more precise treatment strategies.
Source
EurekAlert
Related News
•EurekAlert
New Review Explores Cancer-Inflammation Link and Imaging AI in Precision Therapy
A recent review highlights inflammation’s dual role in cancer progression and how emerging tools like AI and imaging biomarkers are enhancing personalized immunotherapy.
•EurekAlert
AI Model BIOPREVENT Predicts Complications in Stem Cell Transplant Patients
A new AI tool, BIOPREVENT, predicts serious post-transplant complications months before symptoms appear using blood biomarkers and clinical data.
•EurekAlert
CNN-Based AI Enhances Lung Nodule Detection on CT Scans
A CNN-based system achieved high accuracy in detecting and classifying pulmonary nodules using LIDC-IDRI CT data.